Analyst consensus rating
Boundless Bio, Inc. Analyst Rating: Hold
BOLD is rated Hold by 1 analysts with a $4.00 target. As of 2026-08-16.
Direct answer
Boundless Bio, Inc.'s consensus rating is Hold.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.00.
Forecast evidence checked August 16, 2026.
Get free Boundless Bio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.83
- Average price target
- $4.00
- High price target
- $4.00
- Low price target
- $4.00
- Low target gap
- +41.3%
- Target upside
- +41.3%
- High target gap
- +41.3%
- Target range width
- 0%
- Consensus rating
- Hold
- Analysts
- 1
- Evidence date
- August 16, 2026
- Valid through
- August 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Boundless Bio, Inc.?
Boundless Bio, Inc. has a verified Hold consensus. The same dataset has an average price target of $4.00.
How far are Boundless Bio, Inc.'s low and high targets from the recorded price?
The low target implies +41.3%, while the high target implies +41.3%.
How many analysts are included in Boundless Bio, Inc.'s consensus?
The verified consensus includes 1 analysts.
How is Boundless Bio, Inc.'s target upside or downside calculated?
The average target of $4.00 is divided by the recorded price of $2.83, then one is subtracted to produce +41.3%. This does not guarantee a future return.
When was Boundless Bio, Inc.'s analyst forecast verified?
The data was verified on 2026-08-16. The dataset is valid through 2026-08-23.